Experimental drug delays Alzheimer’s in high-risk people
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s,...
Old vaccine shows new promise in fighting Alzheimer’s
Alzheimer’s disease is a type of dementia that affects millions of people around the world. It slowly damages memory and thinking skills, leaving families...
Bacteria use Alzheimer’s-linked proteins as armor in microbial battles
Amyloids, the sticky proteins linked to Alzheimer’s disease, may have a surprising role outside the human brain.
According to new research from the University of...
Smell test may help detect early signs of cognitive decline
A new study from researchers at Mass General Brigham has found that a simple smell test may help detect early signs of memory problems.
The...
Alzheimer’s drug may work differently in men and women
Since receiving approval from the U.S. Food and Drug Administration (FDA) in 2023, the Alzheimer's drug lecanemab—sold under the brand name Leqembi—has seen steady...
Gut inflammation could speed up memory loss, study finds
A new study from Karolinska Institutet in Sweden suggests that people with dementia who also develop inflammatory bowel disease (IBD) may experience a faster...
Air pollution may raise your risk of dementia, Cambridge study finds
Breathing polluted air over long periods could increase your chances of developing dementia, according to a large new study.
Researchers analyzed data from nearly 30...
Personalized brain stimulation could improve walking for people with Parkinson’s
Researchers at UCSF have developed a new, personalized approach to deep brain stimulation (DBS) that significantly improves walking in people with Parkinson’s disease.
The study,...
Did the pandemic age our brains? New study suggests it might have
The COVID-19 pandemic may have aged our brains faster—even if we were never infected with the virus—according to a new study led by researchers...
Cancer drugs may help reverse Alzheimer’s brain changes, study finds
In a groundbreaking study, scientists from UC San Francisco and the Gladstone Institutes have identified two cancer drugs that could help reverse the harmful...